DE69819002D1 - Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln - Google Patents

Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln

Info

Publication number
DE69819002D1
DE69819002D1 DE69819002T DE69819002T DE69819002D1 DE 69819002 D1 DE69819002 D1 DE 69819002D1 DE 69819002 T DE69819002 T DE 69819002T DE 69819002 T DE69819002 T DE 69819002T DE 69819002 D1 DE69819002 D1 DE 69819002D1
Authority
DE
Germany
Prior art keywords
choh
chain
ch2oh
production
products containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69819002T
Other languages
English (en)
Other versions
DE69819002T2 (de
Inventor
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Serge Mignani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9709056A external-priority patent/FR2766181B1/fr
Priority claimed from FR9709206A external-priority patent/FR2766186B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE69819002D1 publication Critical patent/DE69819002D1/de
Application granted granted Critical
Publication of DE69819002T2 publication Critical patent/DE69819002T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69819002T 1997-07-17 1998-07-15 Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln Expired - Lifetime DE69819002T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9709056A FR2766181B1 (fr) 1997-07-17 1997-07-17 Derives de polyhydroxybutylpyrazines, leur preparation et les medicaments les contenant
FR9709056 1997-07-17
FR9709206 1997-07-21
FR9709206A FR2766186B1 (fr) 1997-07-21 1997-07-21 Medicaments contenant des derives de polyhydroxyalkylpyrazine, les nouveaux derives de polyhydroxyalkylpyrazine et leur preparation
PCT/FR1998/001540 WO1999003839A1 (fr) 1997-07-17 1998-07-15 Derives de polyhydroxyalkylpyrazines, leur preparation et les medicaments les contenant

Publications (2)

Publication Number Publication Date
DE69819002D1 true DE69819002D1 (de) 2003-11-20
DE69819002T2 DE69819002T2 (de) 2004-07-29

Family

ID=26233681

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69819002T Expired - Lifetime DE69819002T2 (de) 1997-07-17 1998-07-15 Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln

Country Status (21)

Country Link
US (1) US6362185B1 (de)
EP (1) EP0998464B1 (de)
JP (1) JP4443032B2 (de)
KR (1) KR20010021815A (de)
CN (1) CN1264369A (de)
AT (1) ATE252089T1 (de)
AU (1) AU751588B2 (de)
BR (1) BR9810893A (de)
CA (1) CA2296732C (de)
DE (1) DE69819002T2 (de)
DK (1) DK0998464T3 (de)
ES (1) ES2205535T3 (de)
HU (1) HUP0002403A3 (de)
IL (1) IL134036A0 (de)
MX (1) MXPA00000443A (de)
NO (1) NO20000054D0 (de)
NZ (1) NZ502055A (de)
PL (1) PL338132A1 (de)
RU (1) RU2193032C2 (de)
SK (1) SK452000A3 (de)
WO (1) WO1999003839A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021005009A1 (en) 2019-07-05 2021-01-14 Iomx Therapeutics Ag Antibodies binding igc2 of igsf11 (vsig3) and uses thereof
CN111266090B (zh) * 2020-02-19 2022-11-15 渤海大学 一种快速吸附和选择性分离阳离子染料污染物的吸附分离材料及其应用
EP4175668A1 (de) 2020-07-06 2023-05-10 iOmx Therapeutics AG Igv von igsf11 (vsig3) bindende antikörper und verwendungen davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729990A (ja) * 1993-07-14 1995-01-31 Fujitsu Ltd 半導体装置
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
PL338132A1 (en) 2000-09-25
CA2296732A1 (fr) 1999-01-28
NZ502055A (en) 2001-09-28
CN1264369A (zh) 2000-08-23
WO1999003839A1 (fr) 1999-01-28
EP0998464A1 (de) 2000-05-10
ES2205535T3 (es) 2004-05-01
HUP0002403A3 (en) 2001-07-30
RU2193032C2 (ru) 2002-11-20
JP4443032B2 (ja) 2010-03-31
MXPA00000443A (es) 2002-04-17
CA2296732C (fr) 2008-10-21
BR9810893A (pt) 2000-09-26
AU8810098A (en) 1999-02-10
NO20000054L (no) 2000-01-06
US6362185B1 (en) 2002-03-26
KR20010021815A (ko) 2001-03-15
HUP0002403A2 (en) 2001-05-28
DE69819002T2 (de) 2004-07-29
NO20000054D0 (no) 2000-01-06
SK452000A3 (en) 2000-06-12
ATE252089T1 (de) 2003-11-15
DK0998464T3 (da) 2004-02-16
IL134036A0 (en) 2001-04-30
EP0998464B1 (de) 2003-10-15
AU751588B2 (en) 2002-08-22
JP2001510184A (ja) 2001-07-31

Similar Documents

Publication Publication Date Title
DE69112989D1 (de) Aminocoumaranderivate, ihre Herstellung und Verwendung.
DE69604714T2 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
ATE248824T1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
TR200200648T2 (tr) Farmasötik özelliklere sahip yeni dikarboksilik asit türevleri.
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
ATE288443T1 (de) Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung
ATE73780T1 (de) Glutaminsaeure-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische formulierungen.
PT992509E (pt) Novos derivados macrolidos
ATE260252T1 (de) Thiocolchicin-derivate mit entzündungshemmender und muskelrelaxierender wirkung
DE69819002D1 (de) Polyhydroxyalkylpyrazine derivate,deren herstellung und diese enthaltende arzneimitteln
ATE115558T1 (de) Harnstoffderivate, deren herstellung sowie diese enthaltende pharmazeutische zusammensetzungen.
HUP9601526A2 (hu) Véralvadásgátló hatású peptidil-arginin-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
DE69030502D1 (de) Cephalosporinverbindungen und deren herstellung
DE69917668D1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
ATE140922T1 (de) 3- oder 4-glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches mittel
DE3880304T2 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
DE69511449D1 (de) Octahydro-2-Naphthalincarbonsäure-Derivate, ihre Herstellung und Verwendung
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
ATE241604T1 (de) Polyhydroxyalkylpyrazine derivate und deren herstellung und diese enthaltende arzneimittel
DK0551844T3 (da) Svovlholdige galdesyrederivater
DE69812059D1 (de) Beta,beta-disubstituierte Derivate von 9-Deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC